Identification of an unusual combination of actionable mutations through genomic profiling in a child with an aggressive sarcoma

Pediatr Blood Cancer. 2024 Jan;71(1):e30730. doi: 10.1002/pbc.30730. Epub 2023 Oct 16.

Authors

Shimaa Sherif^{1

2}, Wouter R L Hendrickx^{1

2}, Christophe Michel Raynaud¹, William Mifsud³, Davide Bedognetti^{1

2}, Ata Ur Rehman Maaz⁴

Affiliations

¹ Tumor Biology and Immunology Laboratory, Research Branch, Sidra Medicine, Doha, Qatar.
² College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation, Doha, Qatar.
³ Anatomical Pathology, Sidra Medicine, Doha, Qatar.
⁴ Pediatric Hematology and Oncology Division, Sidra Medicine, Doha, Qatar.

PMID: 37845795
DOI: 10.1002/pbc.30730

No abstract available

Publication types

Letter

MeSH terms

Child
Genomics
High-Throughput Nucleotide Sequencing
Humans
Mutation
Sarcoma* / genetics
Soft Tissue Neoplasms*